Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols / Study 5: Phase 2 and 3 Validations of Putative Breast Cancer Early Detection Candidates

Study 5: Phase 2 and 3 Validations of Putative Breast Cancer Early Detection Candidates

375

No coordinating investigator defined.

No involved investigator sites defined.

UNKNOWN
Breast and Gynecologic Cancers Research
2

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


Announcement 04/26/2017

A new funding opportunity associated with the Beau Biden Cancer Moonshot Initiative, Integration and Validation of Emerging Technologies to Accelerate Cancer Research, has been released and is due May 10, 2017. Click here for more information.

Announcement 03/14/2017

Thank you to everyone who made the March 2017 EDRN Steering Committee Meeting a success. The next EDRN Steering Committee Meeting will be on September 12-14, 2017, in Seattle, WA.

EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.